En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
INNOSUISSE
Numéro de projet
13739.1;7 PFFLI-LS
Titre du projet
¿Body-on-the-Plate¿ - An Integrated Ready-To-Use Platform For Investigating Multi Organ Toxicity
Titre du projet anglais
¿Body-on-the-Plate¿ - An Integrated Ready-To-Use Platform For Investigating Multi Organ Toxicity

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Description succincte
Anzeigen
-
-
Anzeigen
Résumé des résultats (Abstract)
Anzeigen
-
-
Anzeigen

Textes saisis


CatégorieTexte
Description succincte
(Allemand)
'Body-on-the-Plate' - An Integrated Ready-To-Use Platform For Investigating Multi Organ Toxicity
Description succincte
(Anglais)
¿Body-on-the-Plate¿ - An Integrated Ready-To-Use Platform For Investigating Multi Organ Toxicity
Résumé des résultats (Abstract)
(Allemand)
The project goal is the development, production and market launch of a ready-to-use automation compatible in-vitro multi-organ testing platform to investigate efficacy and toxicity of pharmacological active compounds. The intended products allow investigating compound efficacy and toxicity on on-target and offtarget tissues (heart, brain, and kidney) enhacing the predictivity already at an early stage of the drug development process. A total of 4 new products will target an estimated global market size of approx. 100- 200 Mio USD and leverage InSphero's existing international customer base.
Résumé des résultats (Abstract)
(Anglais)
The project goal is the development, production and market launch of a ready-to-use automation compatible in-vitro multi-organ testing platform to investigate efficacy and toxicity of pharmacological active compounds. The intended products allow investigating compound efficacy and toxicity on on-target and offtarget tissues (heart, brain, and kidney) enhacing the predictivity already at an early stage of the drug development process. A total of 4 new products will target an estimated global market size of approx. 100- 200 Mio USD and leverage InSphero¿s existing international customer base.